Development of a reverse transcription-loop-mediated isothermal amplification (RT-LAMP) system for a highly sensitive detection of enterovirus in the stool samples of acute flaccid paralysis cases
© Arita et al; licensee BioMed Central Ltd. 2009
Received: 11 June 2009
Accepted: 16 December 2009
Published: 16 December 2009
In the global eradication program for poliomyelitis, the laboratory diagnosis plays a critical role by isolating poliovirus (PV) from the stool samples of acute flaccid paralysis (AFP) cases. In this study, we developed a reverse transcription-loop-mediated isothermal amplification (RT-LAMP) system for a rapid and highly sensitive detection of enterovirus including PV to identify stool samples positive for enterovirus including PV.
A primer set was designed for RT-LAMP to detect enterovirus preferably those with PV-like 5'NTRs of the viral genome. The sensitivity of RT-LAMP system was evaluated with prototype strains of enterovirus. Detection of enterovirus from stool extracts was examined by using RT-LAMP system.
We detected at least 400 copies of the viral genomes of PV(Sabin) strains within 90 min by RT-LAMP with the primer set. This RT-LAMP system showed a preference for Human enterovirus species C (HEV-C) strains including PV, but exhibited less sensitivity to the prototype strains of HEV-A and HEV-B (detection limits of 7,400 to 28,000 copies). Stool extracts, from which PV, HEV-C, or HEV-A was isolated in the cell culture system, were mostly positive by RT-LAMP method (positive rates of 15/16 (= 94%), 13/14 (= 93%), and 4/4 (= 100%), respectively). The positive rate of this RT-LAMP system for stool extracts from which HEV-B was isolated was lower than that of HEV-C (positive rate of 11/21 (= 52%)). In the stool samples, which were negative for enterovirus isolation by the cell culture system, we found that two samples were positive for RT-LAMP (positive rates of 2/38 (= 5.3%)). In these samples, enterovirus 96 was identified by sequence analysis utilizing a seminested PCR system.
RT-LAMP system developed in this study showed a high sensitivity comparable to that of the cell culture system for the detection of PV, HEV-A, and HEV-C, but less sensitivity to HEV-B. This RT-LAMP system would be useful for the direct detection of enterovirus from the stool extracts.
In the global eradication program for poliomyelitis, the laboratory diagnosis plays a critical role by isolating poliovirus (PV) from the stool samples of acute flaccid paralysis (AFP) cases. The isolation procedure of PV have been established based on the cell culture system using a human rhabdomyosarcoma cell line (RD cells) and a mouse L cell line expressing PV receptor (L20B cells) [1, 2]. The advantages of cell culture-based procedure are; 1) apparatuses for molecular diagnosis are not required, and 2) a high sensitivity (detection limit of 1 infectious dose that contains 50 to 1,000 virions in picornavirus infection) . The disadvantage is that some expertise and quality control system are required for the cell culture system and for the identification of the cytopathic effect of infected cells. As for the timeliness of reporting, the cell culture-based procedure is time-consuming. It takes for 10 days to confirm the sample as PV-negative even after the introduction of the latest procedure "New Algorism" recommended by WHO . Currently, detection of the circulating vaccine-derived PV (cVDPV) has a high priority in the eradication program and will be in the post-eradication era. Therefore, rapid (at the order of day) and sensitive detection of PV in laboratory diagnosis could contribute to shortening of the timeliness of reporting for mop-up vaccine campaign to control cVDPV outbreaks.
Among currently available procedures detecting RNA viruses, a reverse transcription-loop-mediated isothermal amplification (RT-LAMP) system seems to be a most promising method that meet the demands expected for the cell culture-based isolation procedure . The advantages of RT-LAMP system are; 1) minimum essential equipment is an isothermal heat bath (final results can be visibly observed by the increased turbidity), 2) high sensitivity (detection limits of 0.01 PFU for severe acute respiratory syndrome coronavirus, 0.1 PFU for mumps virus, 0.4 focus forming units for hepatitis A virus, 50 copies of viral genomes for swine vesicular disease virus) [6–9], 3) rapid detection (about 1 h), 4) less possibility of cross-contamination between the samples due to the one-step procedure.
In the present study, we have developed a RT-LAMP system for the detection of enterovirus, including PV. This RT-LAMP system showed a high sensitivity comparable to that of the cell culture system for the detection of PV, HEV-A, and HEV-C, but less sensitivity to HEV-B. This RT-LAMP system would be useful for the direct detection of enterovirus from the stool extracts.
RT-LAMP primers for the detection of PV
Sensitivity of RT-LAMP system for the detection of PV
Next, we examined the sensitivity of RT-LAMP system for enterovirus species by using cell culture supernatant of the virus without viral RNA extraction (Figure 3c). Cell culture supernatant of cells infected with PV(Sabin) strains were RT-LAMP positive at dilution of 1:10,000,000, which contains at least 0.73 to 2.4 CCID50 of viruses (about 100 copies of the viral genomes). Echovirus 11 (belonging to HEV-B) and enterovirus 71 (EV71) strains (belonging to HEV-A) showed lower sensitivity in the RT-LAMP reaction compared to PV(Sabin) strains. The detection limit of echovirus 11 and EV71 strains were 17 CCID50 (28,000 copies of the viral genome) and 7.8 to 53 CCID50 (7,400 to 13,000 copies of the viral genome), respectively.
Finally, we examined to detect PV from the stool samples of AFP cases (Figure 3d). Stool samples that were positive for PV (16 samples), HEV-A (4 samples), -B (21 samples), and -C (14 samples), or negative for enterovirus (38 samples) by cell culture-based isolation were examined. PV and HEV-C were detected with high positive rates in the stool samples by RT-LAMP (94 and 93%, respectively). Unexpectedly, HEV-A was also detected with a high positive rate (100%), and HEV-B was also detected with a relatively high positive rate (52%). For stool samples negative for enterovirus, 2 samples (derived from one AFP case) were positive by RT-LAMP. For these samples, enterovirus 96 was identified by sequence analysis of VP1 coding region utilizing a seminested PCR  (data not shown). Therefore, this RT-LAMP system showed a good correlation with the cell culture-based isolation especially for PV, HEV-C, and HEV-A.
In this study, we have developed a RT-LAMP system for a rapid and highly sensitive detection of enterovirus including PV directly from stool samples of AFP cases without cell culture-based procedures. 5'NTR of enteroviruses is classified into two groups based on its primary structure, PV-like or CBV-like 5'NTR [10, 11]. Actually, a RFLP assay utilizing BstOI have been developed to differentiate these genogroups . We designed RT-LAMP primers preferably to detect PV-like 5'NTR rather than PV-specific primers, because we could not find nucleotide sequences specific to PV strains but not to other HEV-C strains in the 5'NTR. Actually, cVDPVs with unknown nucleotide sequences in the 5'NTR, which was probably derived from the viral genome of other non-polio enterovirus, were isolated .
We observed the specificity to PV-like 5'NTR to some extent compared to CBV-like 5'NTR in the RT-LAMP reaction, where about 100-fold difference was observed in the sensitivity (Figure 3c). However, detection of enteroviruses from stool samples showed only slightly lower positive rates for HEV-A and HEV-B (100 and 52%, respectively) compared to those for PV and other HEV-C (94 and 93%, respectively) (Figure 3d). The relatively low positive rates of HEV-B among these virus species might depend on the designed specificity of RT-LAMP to PV-like 5'NTR. Sequence analysis of 5'NTR of HEV-B isolates indicated that these field isolates could have some genetic features similar to PV-like 5'NTR (Figure 4). Therefore, with relatively low specificity of RT-LAMP system (100-fold difference between PV-like and CBV-like 5'NTR), the mixed genetic features of the 5'NTR of HEV-B field isolates might have affected the specificity of the RT-LAMP system.
Titre of PV in stool samples
Virus titre (CCID50/50 μl)
In summary, we developed a highly sensitive RT-LAMP system for the detection of enterovirus, including PV, from the stool extracts. The cell culture-based isolation will be needed for genetic characterization of PV isolates, particularly differentiation of wild, VDPV, and mixtures of PV and enterovirus. The RT-LAMP system would be useful for a triage of overwhelming number of clinical samples to reduce the workload and to minimize the timeliness of the report by identifying the samples negative for PV within a day.
Cells, viruses, and clinical samples
RD cells (human rhabdomyosarcoma cell line) were cultured as monolayers in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal calf serum (FCS) and used for titration of viruses. Virus titre was determined by measuring 50% cell culture infectious dose (CCID50) at 35°C by a microtitration assay . Stool extracts from AFP cases were used for isolation of enterovirus and for RT-LAMP reaction. The species and serotypes of enterovirus isolates were determined by sequencing of the viral genome with a primer set for 2BC coding region (2A2+ and 2C-primers)  and with those for VP1 coding region (292 and 222 primers) . All the clinical samples and virus isolates used in this study are appropriately anonymized. Therefore, they are exempt from the regulation under the Committee for Ethical Regulation of the National Institute of Infectious Diseases.
Viral genomic RNA was purified from the stool extracts of AFP cases by using a High Pure viral RNA purification kit (Roche). In this purification procedure, viral genomic RNA was collected in 50 μl of distilled water purified from 200 μl of stool extracts.
Primers used in this study are shown in Figure 1 (Figure 1b). Stocks of the primers were prepared in distilled water in concentrations as follows; 40 μM for FIP and BIP primers, 5 μM for F and B primers, and 20 μM for Loop B primers. RT-LAMP reaction was performed by using a RNA Amplification Kit (RT-LAMP) (Eiken Chemical Co. Ltd., Tokyo, Japan). RT-LAMP reaction was prepared according to the manufacturer's instruction but in a total 12.5 μl reaction. The final concentrations of the primers were as follows; 1.6 μM for FIP and BIP primers, 0.2 μM for F and B primers, and 0.8 μM for Loop B primers. In the total 12.5 μl reaction, 2.5 μl of purified viral RNA solution or diluted cell culture supernatant were included (Figure 1c). RT-LAMP reaction was performed at 60°C for 90 min and optical density at 650 nm was measured as the turbidity by a Loopamp Realtime Turbidimeter LA-320C (Teramecs, Kyoto, Japan). The threshold of the turbidity for RT-LAMP positive sample was defined at 0.1 in the measurement . The numbers of copies of the viral RNA of PV Sabin strains and prototype enterovirus strains were determined by real-time TaqMan PCR system developed by Nijhuis et al. , as described previously .
We thank Dr. Keith Feldon, Dr. Kohei Toda, and Cambodian local and regional EPI staffs for their expert surveillance. We are grateful to Junko Wada for her excellent technical assistance.
This study was supported in part by Grants-in-Aid for the Promotion of Polio Eradication and Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labour and Welfare.
- Wood DJ, Hull B: L20B cells simplify culture of polioviruses from clinical samples. J Med Virol. 1999, 58: 188-192. 10.1002/(SICI)1096-9071(199906)58:2<188::AID-JMV15>3.0.CO;2-H.View ArticlePubMedGoogle Scholar
- World Health Organization: Polio Laboratory Manual WHO/IVB/0410 and Supplement to the WHO Polio Laboratory Manual, World Health Organization. 2004, 4Google Scholar
- Rueckert RR: Picornaviridae: the viruses and their replication. Fields virology. Edited by: Fields BN, Knipe DM, Howley PM. 1996, Lippincott-Raven, Philadelphia, PA, 1: 609-654. 3Google Scholar
- Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T: Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000, 28: E63-10.1093/nar/28.12.e63.View ArticlePubMedPubMed CentralGoogle Scholar
- Mori Y, Kitao M, Tomita N, Notomi T: Real-time turbidimetry of LAMP reaction for quantifying template DNA. J Biochem Biophys Methods. 2004, 59: 145-157. 10.1016/j.jbbm.2003.12.005.View ArticlePubMedGoogle Scholar
- Blomstrom AL, Hakhverdyan M, Reid SM, Dukes JP, King DP, Belak S, Berg M: A one-step reverse transcriptase loop-mediated isothermal amplification assay for simple and rapid detection of swine vesicular disease virus. J Virol Methods. 2008, 147: 188-193. 10.1016/j.jviromet.2007.08.023.View ArticlePubMedGoogle Scholar
- Hong TC, Mai QL, Cuong DV, Parida M, Minekawa H, Notomi T, Hasebe F, Morita K: Development and evaluation of a novel loop-mediated isothermal amplification method for rapid detection of severe acute respiratory syndrome coronavirus. J Clin Microbiol. 2004, 42: 1956-1961. 10.1128/JCM.42.5.1956-1961.2004.View ArticlePubMedGoogle Scholar
- Okafuji T, Yoshida N, Fujino M, Motegi Y, Ihara T, Ota Y, Notomi T, Nakayama T: Rapid diagnostic method for detection of mumps virus genome by loop-mediated isothermal amplification. J Clin Microbiol. 2005, 43: 1625-1631. 10.1128/JCM.43.4.1625-1631.2005.View ArticlePubMedPubMed CentralGoogle Scholar
- Yoneyama T, Kiyohara T, Shimasaki N, Kobayashi G, Ota Y, Notomi T, Totsuka A, Wakita T: Rapid and real-time detection of hepatitis A virus by reverse transcription loop-mediated isothermal amplification assay. J Virol Methods. 2007, 145: 162-168. 10.1016/j.jviromet.2007.05.023.View ArticlePubMedGoogle Scholar
- Poyry T, Kinnunen L, Hyypia T, Brown B, Horsnell C, Hovi T, Stanway G: Genetic and phylogenetic clustering of enteroviruses. J Gen Virol. 1996, 77 (Pt 8): 1699-1717. 10.1099/0022-1317-77-8-1699.View ArticlePubMedGoogle Scholar
- Siafakas N, Markoulatos P, Stanway G: Molecular classification of coxsackie A viruses on the basis of the 5'-UTR: structural and evolutionary aspects. J Mol Evol. 2002, 55: 638-652. 10.1007/s00239-002-2359-4.View ArticlePubMedGoogle Scholar
- Nix WA, Oberste MS, Pallansch MA: Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol. 2006, 44: 2698-2704. 10.1128/JCM.00542-06.View ArticlePubMedPubMed CentralGoogle Scholar
- Siafakas N, Markoulatos P, Stanway G, Tzanakaki G, Kourea-Kremastinou J: A reliable RT-PCR/RFLP assay for the molecular classification of enterovirus reference and wild type strains to either of the two genetic clusters on the basis of 5'-UTR. Mol Cell Probes. 2002, 16: 209-216. 10.1006/mcpr.2002.0414.View ArticlePubMedGoogle Scholar
- Yang CF, Naguib T, Yang SJ, Nasr E, Jorba J, Ahmed N, Campagnoli R, Avoort van der H, Shimizu H, Yoneyama T, et al: Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol. 2003, 77: 8366-8377. 10.1128/JVI.77.15.8366-8377.2003.View ArticlePubMedPubMed CentralGoogle Scholar
- Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib Z, Andre J, Blackman E, Freeman CJ, Jorba J, et al: Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science. 2002, 296: 356-359. 10.1126/science.1068284.View ArticlePubMedGoogle Scholar
- Odoom JK, Yunus Z, Dunn G, Minor PD, Martin J: Changes in population dynamics during long-term evolution of sabin type 1 poliovirus in an immunodeficient patient. J Virol. 2008, 82: 9179-9190. 10.1128/JVI.00468-08.View ArticlePubMedPubMed CentralGoogle Scholar
- Nijhuis M, van Maarseveen N, Schuurman R, Verkuijlen S, de Vos M, Hendriksen K, van Loon AM: Rapid and sensitive routine detection of all members of the genus enterovirus in different clinical specimens by real-time PCR. J Clin Microbiol. 2002, 40: 3666-3670. 10.1128/JCM.40.10.3666-3670.2002.View ArticlePubMedPubMed CentralGoogle Scholar
- Nagata N, Shimizu H, Ami Y, Tano Y, Harashima A, Suzaki Y, Sato Y, Miyamura T, Sata T, Iwasaki T: Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J Med Virol. 2002, 67: 207-216. 10.1002/jmv.2209.View ArticlePubMedGoogle Scholar
- Arita M, Zhu SL, Yoshida H, Yoneyama T, Miyamura T, Shimizu H: A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region. J Virol. 2005, 79: 12650-12657. 10.1128/JVI.79.20.12650-12657.2005.View ArticlePubMedPubMed CentralGoogle Scholar
- Oberste MS, Nix WA, Maher K, Pallansch MA: Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J Clin Virol. 2003, 26: 375-377. 10.1016/S1386-6532(03)00004-0.View ArticlePubMedGoogle Scholar
- Arita M, Ami Y, Wakita T, Shimizu H: Cooperative effect of the attenuation determinants derived from poliovirus Sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol. 2008, 82: 1787-1797. 10.1128/JVI.01798-07.View ArticlePubMedGoogle Scholar
- Pilipenko EV, Blinov VM, Romanova LI, Sinyakov AN, Maslova SV, Agol VI: Conserved structural domains in the 5'-untranslated region of picornaviral genomes: an analysis of the segment controlling translation and neurovirulence. Virology. 1989, 168: 201-209. 10.1016/0042-6822(89)90259-6.View ArticlePubMedGoogle Scholar
- Skinner MA, Racaniello VR, Dunn G, Cooper J, Minor PD, Almond JW: New model for the secondary structure of the 5' non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J Mol Biol. 1989, 207: 379-392. 10.1016/0022-2836(89)90261-1.View ArticlePubMedGoogle Scholar
- Andino R, Rieckhof GE, Baltimore D: A functional ribonucleoprotein complex forms around the 5' end of poliovirus RNA. Cell. 1990, 63: 369-380. 10.1016/0092-8674(90)90170-J.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/9/208/prepub